Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Antibiotic discontinuation through an antibiotic treatment optimization program in emergency department patients with low suspicion of infection
Paula Martínez-de la Cruz; Leonor Moreno-Núñez; Sara Álvarez-Atienza; Sira Sanz-Márquez; José Francisco Valverde-Canovas; Juan Emilio Losa-García;
Enferm Infecc Microbiol Clin. 2023;41:423-5
Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?
Marta Díaz-Navarro; Rama Hafian; María Jesús Pérez-Granda; Emilia Cercenado; Patricia Muñoz; María Guembe;
Enferm Infecc Microbiol Clin. 2024;42:435-8
Dalbavancin as sequential therapy in infective endocarditis: Real-life experience in elder and comorbid patients
Eduardo Aparicio-Minguijón; Jorge Boán; Antonio Terrón; Carlos Heredia; Cristina Puente; Asunción Pérez-Jacoiste Asín; M. Ángeles Orellana; Laura Domínguez; José Manuel Caro; M. Jesús López-Gude; Eva María Aguilar-Blanco; Andrea Eixerés-Esteve; Francisco López-Medrano;
10.1016/j.eimce.2024.04.012